LuCaP Prostate Cancer Patient-Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics
-
- Holly M. Nguyen
- Department of Urology; University of Washington; Seattle Washington
-
- Robert L. Vessella
- Department of Urology; University of Washington; Seattle Washington
-
- Colm Morrissey
- Department of Urology; University of Washington; Seattle Washington
-
- Lisha G. Brown
- Department of Urology; University of Washington; Seattle Washington
-
- Ilsa M. Coleman
- Division of Human Biology; Fred Hutchinson Cancer Research Center; Seattle Washington
-
- Celestia S. Higano
- Division of Clinical Research; Fred Hutchinson Cancer Research Center; Seattle Washington
-
- Elahe A. Mostaghel
- Division of Clinical Research; Fred Hutchinson Cancer Research Center; Seattle Washington
-
- Xiaotun Zhang
- Department of Urology; University of Washington; Seattle Washington
-
- Lawrence D. True
- Department of Pathology; University of Washington; Seattle Washington
-
- Hung-Ming Lam
- Department of Urology; University of Washington; Seattle Washington
-
- Martine Roudier
- Department of Urology; University of Washington; Seattle Washington
-
- Paul H. Lange
- Department of Urology; University of Washington; Seattle Washington
-
- Peter S. Nelson
- Department of Urology; University of Washington; Seattle Washington
-
- Eva Corey
- Department of Urology; University of Washington; Seattle Washington
書誌事項
- タイトル別名
-
- Prostate Cancer PDXs: LuCaP Series
収録刊行物
-
- The Prostate
-
The Prostate 77 (6), 654-671, 2017-02-03
Wiley